Researchers say a new analysis of BioDelivery Sciences International's pain patch Bema Fentanyl shows the therapy demonstrated statistically significant results against breakthrough pain in half the time demonstrated in an earlier analysis. Last month the company said that the patch achieved significant results in 30 minutes, but researchers say that it was able to reduce breakthrough pain in 15 minutes. BDSI is preparing to file a marketing application for the patch in the third quarter and says sales should peak at $250 million.
- here's the AP report on the new data